Terms: = Breast cancer AND NF1, NFNS, 4763, ENSG00000196712, P21359 AND Prognosis
20 results:
1. Omics sciences and precision medicine in sarcoma.
Bonetti G; Donato K; Dhuli K; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Bernini A; Fulcheri E; Cavalca D; Stuppia L; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):68-76. PubMed ID: 37994750
[TBL] [Abstract] [Full Text] [Related]
2. Genetic Aspects of Conjunctival Melanoma: A Review.
Chang E; Demirci H; Demirci FY
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
[TBL] [Abstract] [Full Text] [Related]
3. PDE4DIP contributes to colorectal cancer growth and chemoresistance through modulation of the nf1/RAS signaling axis.
Pan R; Dai J; Liang W; Wang H; Ye L; Ye S; Lin Z; Huang S; Xiong Y; Zhang L; Lu L; Wang O; Shen X; Liao W; Lu X
Cell Death Dis; 2023 Jun; 14(6):373. PubMed ID: 37355626
[TBL] [Abstract] [Full Text] [Related]
4. Long-term Survival in breast cancer Patients Is Associated with Contralateral Parenchymal Enhancement at MRI: Outcomes of the SELECT Study.
Ragusi MAA; van der Velden BHM; Meeuwis C; Tetteroo E; Coerkamp EG; van Nijnatten TJA; Jansen FH; Wolters-van der Ben EJM; Jongen L; van Raamt F; Dorrius MD; Verloop J; Viergever MA; Pijnappel RM; Elias SG; Gilhuijs KGA
Radiology; 2023 May; 307(4):e221922. PubMed ID: 36975820
[TBL] [Abstract] [Full Text] [Related]
5. Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea.
Yun J; Song H; Kim SM; Kim S; Kwon SR; Lee YE; Jeong D; Park JH; Kwon S; Yun H; Lee DS
Hum Genomics; 2023 Feb; 17(1):13. PubMed ID: 36814285
[TBL] [Abstract] [Full Text] [Related]
6. MicroRNA-217 aggravates breast cancer through activation of nf1-mediated HSF1/ATG7 axis and c-Jun/ATF3/MMP13 axis.
Li W; Yang C; Li J; Li X; Zhou P
Hum Cell; 2023 Jan; 36(1):377-392. PubMed ID: 36357766
[TBL] [Abstract] [Full Text] [Related]
7. Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in breast cancer.
Stella S; Vitale SR; Massimino M; Motta G; Longhitano C; Lanzafame K; Martorana F; Fazzari C; Vecchio GM; Tirrò E; Inzerilli N; Carciotto R; Manzella L; Caruso M; Vigneri P
Cancer Genomics Proteomics; 2022; 19(4):464-476. PubMed ID: 35732329
[TBL] [Abstract] [Full Text] [Related]
8. The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1.
Crook A; Kwa R; Ephraums S; Wilding M; Thiyagarajan L; Fleming J; Moore K; Berman Y
Fam Cancer; 2022 Apr; 21(2):241-253. PubMed ID: 33963463
[TBL] [Abstract] [Full Text] [Related]
9. Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in breast cancer.
Zheng ZY; Anurag M; Lei JT; Cao J; Singh P; Peng J; Kennedy H; Nguyen NC; Chen Y; Lavere P; Li J; Du XH; Cakar B; Song W; Kim BJ; Shi J; Seker S; Chan DW; Zhao GQ; Chen X; Banks KC; Lanman RB; Shafaee MN; Zhang XH; Vasaikar S; Zhang B; Hilsenbeck SG; Li W; Foulds CE; Ellis MJ; Chang EC
Cancer Cell; 2020 Mar; 37(3):387-402.e7. PubMed ID: 32142667
[TBL] [Abstract] [Full Text] [Related]
10.
Tang Y; Li J; Xie N; Yang X; Liu L; Wu H; Tian C; He Y; Wang X; He Q; Hu ZY; Ouyang Q
Aging (Albany NY); 2020 Jan; 12(2):1577-1590. PubMed ID: 31980592
[TBL] [Abstract] [Full Text] [Related]
11. Mutation of the PTCH1 gene predicts recurrence of breast cancer.
Wang CY; Chang YC; Kuo YL; Lee KT; Chen PS; Cheung CHA; Chang CP; Phan NN; Shen MR; Hsu HP
Sci Rep; 2019 Nov; 9(1):16359. PubMed ID: 31704974
[TBL] [Abstract] [Full Text] [Related]
12. breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study.
Evans DGR; Kallionpää RA; Clementi M; Trevisson E; Mautner VF; Howell SJ; Lewis L; Zehou O; Peltonen S; Brunello A; Harkness EF; Wolkenstein P; Peltonen J
Genet Med; 2020 Feb; 22(2):398-406. PubMed ID: 31495828
[TBL] [Abstract] [Full Text] [Related]
13. Papillary Lesions of the Male breast: A Study of 117 Cases and Brief Review of the Literature Demonstrate a Broad Clinicopathologic Spectrum.
Zhong E; Cheng E; Goldfischer M; Hoda SA
Am J Surg Pathol; 2020 Jan; 44(1):68-76. PubMed ID: 31403965
[TBL] [Abstract] [Full Text] [Related]
14. Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications.
McCart Reed AE; Kalaw E; Nones K; Bettington M; Lim M; Bennett J; Johnstone K; Kutasovic JR; Saunus JM; Kazakoff S; Xu Q; Wood S; Holmes O; Leonard C; Reid LE; Black D; Niland C; Ferguson K; Gresshoff I; Raghavendra A; Harvey K; Cooper C; Liu C; Kalinowski L; Reid AS; Davidson M; Pearson JV; Pathmanathan N; Tse G; Papadimos D; Pathmanathan R; Harris G; Yamaguchi R; Tan PH; Fox SB; O'Toole SA; Simpson PT; Waddell N; Lakhani SR
J Pathol; 2019 Feb; 247(2):214-227. PubMed ID: 30350370
[TBL] [Abstract] [Full Text] [Related]
15. Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609).
Liang X; Briaux A; Becette V; Benoist C; Boulai A; Chemlali W; Schnitzler A; Baulande S; Rivera S; Mouret-Reynier MA; Bouvet LV; De La Motte Rouge T; Lemonnier J; Lerebours F; Callens C
J Hematol Oncol; 2018 Oct; 11(1):124. PubMed ID: 30305115
[TBL] [Abstract] [Full Text] [Related]
16. The prognostic effects of somatic mutations in ER-positive breast cancer.
Griffith OL; Spies NC; Anurag M; Griffith M; Luo J; Tu D; Yeo B; Kunisaki J; Miller CA; Krysiak K; Hundal J; Ainscough BJ; Skidmore ZL; Campbell K; Kumar R; Fronick C; Cook L; Snider JE; Davies S; Kavuri SM; Chang EC; Magrini V; Larson DE; Fulton RS; Liu S; Leung S; Voduc D; Bose R; Dowsett M; Wilson RK; Nielsen TO; Mardis ER; Ellis MJ
Nat Commun; 2018 Sep; 9(1):3476. PubMed ID: 30181556
[TBL] [Abstract] [Full Text] [Related]
17. Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity.
Suarez-Kelly LP; Akagi K; Reeser JW; Samorodnitsky E; Reeder M; Smith A; Roychowdhury S; Symer DE; Carson WE
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29449315
[TBL] [Abstract] [Full Text] [Related]
18. A mutational comparison of adult and adolescent and young adult (AYA) colon cancer.
Tricoli JV; Boardman LA; Patidar R; Sindiri S; Jang JS; Walsh WD; McGregor PM; Camalier CE; Mehaffey MG; Furman WL; Bahrami A; Williams PM; Lih CJ; Conley BA; Khan J
Cancer; 2018 Mar; 124(5):1070-1082. PubMed ID: 29194591
[TBL] [Abstract] [Full Text] [Related]
19. Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities.
Craig DW; O'Shaughnessy JA; Kiefer JA; Aldrich J; Sinari S; Moses TM; Wong S; Dinh J; Christoforides A; Blum JL; Aitelli CL; Osborne CR; Izatt T; Kurdoglu A; Baker A; Koeman J; Barbacioru C; Sakarya O; De La Vega FM; Siddiqui A; Hoang L; Billings PR; Salhia B; Tolcher AW; Trent JM; Mousses S; Von Hoff D; Carpten JD
Mol Cancer Ther; 2013 Jan; 12(1):104-16. PubMed ID: 23171949
[TBL] [Abstract] [Full Text] [Related]
20. Unilateral gynecomastia and pseudoangiomatous stromal hyperplasia in neurofibromatosis: case report and review of the literature.
Kimura S; Tanimoto A; Shimajiri S; Sasaguri T; Yamada S; Wang KY; Guo X; Sasaguri Y
Pathol Res Pract; 2012 May; 208(5):318-22. PubMed ID: 22520406
[TBL] [Abstract] [Full Text] [Related]
